BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32876219)

  • 1. Clinical characteristics of thyroid cancer in Manizales, Colombia, 2008-2015.
    Arias-Ortiz NE; Guzmán-Gallego EA
    Rev Peru Med Exp Salud Publica; 2020; 37(2):287-291. PubMed ID: 32876219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological variants and prognostic factors of papillary thyroid carcinoma at the Colombian Instituto Nacional de Cancerología, 2006-2012.
    Romero-Rojas A; Cuervo-Martínez J; Osorio-Arango K; Olaya N
    Biomedica; 2015; 35(3):429-36. PubMed ID: 26849704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent, aggressive behaviors of thyroid microcarcinomas in korean patients.
    Lee J; Rhee Y; Lee S; Ahn CW; Cha BS; Kim KR; Lee HC; Kim SI; Park CS; Lim SK
    Endocr J; 2006 Oct; 53(5):627-32. PubMed ID: 16896263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
    Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
    Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological difference in adult thyroid papillary carcinoma between Japan and Ukraine.
    Ito M; Bogdanova T; Zurnadzhy L; Saenko V; Rogounovitch T; Mitsutake N; Kondo H; Maeda S; Nakashima M; Tronko M; Yamashita S
    Endocr J; 2014; 61(12):1221-8. PubMed ID: 25242260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine.
    Bogdanova TI; Saenko VA; Hirokawa M; Ito M; Zurnadzhy LY; Hayashi T; Rogounovitch TI; Miyauchi A; Tronko MD; Yamashita S
    Endocr J; 2017 Oct; 64(10):977-993. PubMed ID: 28794343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
    Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
    Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male sex is associated with aggressive behaviour and poor prognosis in Chinese papillary thyroid carcinoma.
    Ding J; Wu W; Fang J; Zhao J; Jiang L
    Sci Rep; 2020 Mar; 10(1):4141. PubMed ID: 32139703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients.
    Yin X; Liu C; Guo Y; Li X; Shen N; Zhao X; Yu P; Wang S; Liu Z
    World J Surg Oncol; 2017 Jul; 15(1):133. PubMed ID: 28716127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated thyroid cancer in children and adolescents.
    Farahati J; Parlowsky T; Mäder U; Reiners C; Bucsky P
    Langenbecks Arch Surg; 1998 Aug; 383(3-4):235-9. PubMed ID: 9776448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A descriptive study of papillary thyroid carcinoma in a teaching hospital in Chennai, India.
    Dorairajan N; Pandiarajan R; Yuvaraja S
    Asian J Surg; 2002 Oct; 25(4):300-3. PubMed ID: 12471002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Ince S; Arslan N
    Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthyroidism in patients with thyroid cancer.
    Sharma SD; Kumar G; Guner K; Kaddour H
    Ear Nose Throat J; 2016 Jun; 95(6):236-9. PubMed ID: 27304444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma.
    Luo D; Chen H; Lu P; Li X; Long M; Peng X; Huang M; Huang K; Lin S; Tan L; Zhu Y; Chen Z; Ouyang N; Li H
    Cancer Biomark; 2017; 18(3):273-284. PubMed ID: 28009325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic pathology of occult thyroid carcinomas.
    Fukunaga FH; Yatani R
    Cancer; 1975 Sep; 36(3):1095-9. PubMed ID: 1182663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.